We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Irinotecan

News List

Liposomal Irinotecan: A New Hope for The First-line Treatment of Metastatic Pancreatic Cancer YuZai
July 03, 2024
Pancreatic cancer, known as the king of cancer, was diagnosed with pancreatic ductal adenocarcinoma in approximately 496,000 people worldwide in 2020 and is the seventh leading cause of cancer-related deaths.
First-in-Human Clinical Data Shows SonoTran® is Safe and Well-Tolerated PharmaSources
January 23, 2023
OxSonics Therapeutics, announces that first-in-human clinical data demonstrated that SonoTran® is safe and well-tolerated, with consistent Particle activation observed and mapped using OxSonics’ proprietary “see-as-you-treat” technology.